Junying Li

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cells.

SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cells.

Journal: Leukemia

Published: October 17, 2024

A survey on the situation and risk factors of secondary infection after the second wave of the Omicron COVID-19 in China.

A survey on the situation and risk factors of secondary infection after the second wave of the Omicron COVID-19 in China.

Journal: Journal of infection in developing countries

Published: October 06, 2024

Circulating plasma cells as a predictive biomarker in Multiple myeloma: an updated systematic review and meta-analysis.

Circulating plasma cells as a predictive biomarker in Multiple myeloma: an updated systematic review and meta-analysis.

Journal: Annals of medicine

Published: April 10, 2024

Class II ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myeloma.

Class II ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myeloma.

Journal: Blood advances

Published: December 13, 2023

Hematologists' awareness of venous thromboembolism in multiple myeloma: a national survey in China.

Hematologists' awareness of venous thromboembolism in multiple myeloma: a national survey in China.

Journal: Annals of medicine

Published: November 20, 2023

The predictive value of MiR-221 in cancer chemoresistance: a systematic review and meta-analysis.

The predictive value of MiR-221 in cancer chemoresistance: a systematic review and meta-analysis.

Journal: Expert review of anticancer therapy

Published: June 05, 2023

Hematological Questions in Personalized Management of COVID-19 Vaccination.

Hematological Questions in Personalized Management of COVID-19 Vaccination.

Journal: Journal of personalized medicine

Published: December 17, 2022

CCL18 promotes migration and invasion of multiple myeloma cells and is associated with poor prognosis.

CCL18 promotes migration and invasion of multiple myeloma cells and is associated with poor prognosis.

Journal: Carcinogenesis

Published: September 18, 2022

COVID-19 in patients with multiple myeloma: a cross-sectional survey from the most severely affected region in China.

COVID-19 in patients with multiple myeloma: a cross-sectional survey from the most severely affected region in China.

Journal: Leukemia & lymphoma

Published: December 03, 2020

Idarubicin-Intensified Hematopoietic Cell Transplantation Improves Relapse and Survival of High-Risk Acute Leukemia Patients with Minimal Residual Disease.

Idarubicin-Intensified Hematopoietic Cell Transplantation Improves Relapse and Survival of High-Risk Acute Leukemia Patients with Minimal Residual Disease.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: May 04, 2018

MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling.

MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling.

Journal: International journal of cancer

Published: February 25, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026